May 8 |
Beam Therapeutics (BEAM) Q1 Loss Narrows, Revenues Miss
|
May 8 |
Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference
|
May 8 |
Beam Therapeutics Inc (BEAM) Reports Q1 2024 Earnings: A Detailed Overview
|
May 7 |
Beam Therapeutics GAAP EPS of -$1.21 beats by $0.23, revenue of $7.41M misses by $7.25M
|
May 7 |
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
|
May 2 |
Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates
|
May 1 |
Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|